Skip to Content
MilliporeSigma

Key Documents

View All Documentation

SML4113

OGT2115

≥97% (HPLC)

Synonym(s):

2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propen-1-yl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid, 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid, OGT 2115, OGT-2115

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C24H16BrFN2O4
CAS Number:
853929-59-6
Molecular Weight:
495.30
MDL number:
MFCD12828743
NACRES:
NA.28
Assay:
≥97% (HPLC)
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Segment

100

assay

≥97% (HPLC)

form

powder

color

white to beige

solubility

soluble (DMSO:0.1M NaOH (95:5), 1.0 mg/mL, clear, warmed, may need to sonicate.)

storage temp.

-10 to -25°C

Biochem/physiol Actions

Heparanase (HPSE) inhibitor with anti-angiogenesis potency and no inhibition of major human cytochrome P450 enzymes.

OGT 2115 is a heparanase (HPSE) inhibitor (IC50 = 0.4 μM) with anti-angiogenesis potency in human endothelial cell cultures (tubule formation IC50 = 1 μM) and no inhibition of major human cytochrome P450 enzymes (Cyp3A4 & Cyp2C9 IC50 > 30 μM).

pictograms

Skull and crossbones
GHS06

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library